Xiaoqing Chen

Author PubWeight™ 171.12‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007 29.23
2 Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet 2008 6.22
3 Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet 2010 4.51
4 Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013 4.35
5 A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet 2010 3.86
6 RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet 2007 3.63
7 Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst 2002 3.46
8 Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 2008 3.41
9 A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription. Cell 2005 3.22
10 Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet 2012 3.20
11 Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet 2011 2.72
12 Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 2009 2.13
13 Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res 2010 1.90
14 19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res 2012 1.81
15 Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun 2013 1.73
16 ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas. Gynecol Oncol 2013 1.61
17 Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res 2009 1.59
18 Association of ESR1 gene tagging SNPs with breast cancer risk. Hum Mol Genet 2009 1.58
19 Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. PLoS Genet 2010 1.56
20 Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet 2011 1.56
21 Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 2011 1.51
22 Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". PLoS Genet 2010 1.47
23 Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Hum Mol Genet 2009 1.42
24 Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 2010 1.41
25 Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Res 2012 1.38
26 Rare variants in the ATM gene and risk of breast cancer. Breast Cancer Res 2011 1.36
27 Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis. J Natl Cancer Inst 2008 1.36
28 11q13 is a susceptibility locus for hormone receptor positive breast cancer. Hum Mutat 2012 1.26
29 Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients. Arthritis Res Ther 2008 1.23
30 Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer. Cancer Epidemiol Biomarkers Prev 2011 1.23
31 The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years. Cancer Epidemiol Biomarkers Prev 2002 1.21
32 Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers. PLoS One 2011 1.20
33 Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. Int J Cancer 2011 1.17
34 Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival. J Natl Cancer Inst 2010 1.17
35 Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev 2012 1.17
36 Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer. Cancer Epidemiol Biomarkers Prev 2005 1.14
37 Assessment of hepatocyte growth factor in ovarian cancer mortality. Cancer Epidemiol Biomarkers Prev 2011 1.14
38 Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS One 2012 1.13
39 Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS Biol 2011 1.12
40 Posterior interbody fusion using a diagonal cage with unilateral transpedicular screw fixation for lumbar stenosis. J Clin Neurosci 2011 1.10
41 The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer. Pharmacogenetics 2002 1.10
42 BRCA2 Arg372Hispolymorphism and epithelial ovarian cancer risk. Int J Cancer 2003 1.05
43 The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 2004 1.04
44 Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev 2010 1.01
45 Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Hum Mutat 2012 0.98
46 Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies. Breast Cancer Res Treat 2007 0.98
47 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 2012 0.95
48 The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case-control and family analysis. Breast Cancer Res Treat 2008 0.95
49 The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women. Cancer Epidemiol Biomarkers Prev 2002 0.94
50 Post-endocytic fates of delta-opioid receptor are regulated by GRK2-mediated receptor phosphorylation and distinct beta-arrestin isoforms. J Neurochem 2008 0.94
51 Beta-arrestin1 and beta-arrestin2 are differentially required for phosphorylation-dependent and -independent internalization of delta-opioid receptors. J Neurochem 2005 0.93
52 No evidence for an association between the earwax-associated polymorphism in ABCC11 and breast cancer risk in Caucasian women. Breast Cancer Res Treat 2010 0.92
53 Advance in dietary polyphenols as α-glucosidases inhibitors: a review on structure-activity relationship aspect. Crit Rev Food Sci Nutr 2013 0.90
54 A review on structure-activity relationship of dietary polyphenols inhibiting α-amylase. Crit Rev Food Sci Nutr 2013 0.89
55 Two ATM variants and breast cancer risk. Hum Mutat 2005 0.89
56 A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev 2012 0.89
57 Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. Cancer Epidemiol Biomarkers Prev 2008 0.89
58 Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. Hum Mol Genet 2011 0.89
59 Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers. Breast Cancer Res 2012 0.88
60 A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2007 0.87
61 NF-kB activity-dependent P-selectin involved in ox-LDL-induced foam cell formation in U937 cell. Biochem Biophys Res Commun 2011 0.87
62 Evaluation of calcium phosphate and calcium sulfate as injectable bone cements in sheep vertebrae. J Spinal Disord Tech 2012 0.87
63 Prohibitin 3' untranslated region polymorphism and breast cancer risk in Australian women. Lancet 2002 0.87
64 Migration of retinal pigment epithelium cells is regulated by protein kinase Cα in vitro. Invest Ophthalmol Vis Sci 2013 0.86
65 Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk. Mol Carcinog 2010 0.86
66 Amino-terminated generation 2 poly(amidoamine) dendrimer as a potential broad-spectrum, nonresistance-inducing antibacterial agent. AAPS J 2012 0.85
67 Antibacterial activities of flavonoids: structure-activity relationship and mechanism. Curr Med Chem 2015 0.85
68 Cepharanthine, an alkaloid from Stephania cepharantha Hayata, inhibits the inflammatory response in the RAW264.7 cell and mouse models. Inflammation 2014 0.84
69 No evidence that GATA3 rs570613 SNP modifies breast cancer risk. Breast Cancer Res Treat 2008 0.84
70 Phosphorylation state of mu-opioid receptor determines the alternative recycling of receptor via Rab4 or Rab11 pathway. Mol Endocrinol 2008 0.84
71 Apolipoprotein E-knockout mice show increased titers of serum anti-nuclear and anti-dsDNA antibodies. Biochem Biophys Res Commun 2012 0.84
72 Doxycycline-mediated inhibition of corneal angiogenesis: an MMP-independent mechanism. Invest Ophthalmol Vis Sci 2013 0.83
73 No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer. Breast Cancer Res 2002 0.83
74 Surgical Management of Old Lower Cervical Dislocations With Locked Facet. Clin Spine Surg 2016 0.83
75 Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev 2011 0.83
76 Enhancement of diallyl disulfide-induced apoptosis by inhibitors of MAPKs in human HepG2 hepatoma cells. Biochem Pharmacol 2004 0.83
77 Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005 0.83
78 Genome-wide significant risk associations for mucinous ovarian carcinoma. Nat Genet 2015 0.83
79 Fluorimetric determination of phytic acid in urine based on replacement reaction. Anal Chim Acta 2007 0.83
80 Role of toll-like receptor 4 on lupus lung injury and atherosclerosis in LPS-challenge ApoE⁻/⁻ mice. Clin Dev Immunol 2013 0.82
81 No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 2008 0.82
82 Programmable engineering of a biosensing interface with tetrahedral DNA nanostructures for ultrasensitive DNA detection. Angew Chem Int Ed Engl 2014 0.82
83 Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers. Breast Cancer Res 2010 0.82
84 A BRCA1 promoter variant (rs11655505) and breast cancer risk. J Med Genet 2010 0.81
85 Glycyrrhizic acid as the antiviral component of Glycyrrhiza uralensis Fisch. against coxsackievirus A16 and enterovirus 71 of hand foot and mouth disease. J Ethnopharmacol 2013 0.81
86 Advance in dietary polyphenols as aldose reductases inhibitors: structure-activity relationship aspect. Crit Rev Food Sci Nutr 2015 0.81
87 Efficient and balanced charge transport revealed in planar perovskite solar cells. ACS Appl Mater Interfaces 2015 0.81
88 The prohibitin 3' untranslated region polymorphism is not associated with risk of ovarian cancer. Gynecol Oncol 2003 0.81
89 Severe acute respiratory syndrome epidemic and change of people's health behavior in China. Health Educ Res 2004 0.81
90 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium. J Med Genet 2011 0.80
91 Separation and purification of bovine serum albumin binders from Fructus polygoni orientalis using off-line two-dimensional complexation high-speed counter-current chromatography target-guided by ligand fishing. J Chromatogr A 2013 0.80
92 Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2. PLoS One 2012 0.80
93 Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium. Twin Res Hum Genet 2009 0.79
94 Influence of B-ring hydroxylation on interactions of flavonols with bovine serum albumin. J Agric Food Chem 2008 0.79
95 Tissue distribution profiles of three antiparkinsonian alkaloids from Piper longum L. in rats determined by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2013 0.79
96 Exploring the link between MORF4L1 and risk of breast cancer. Breast Cancer Res 2011 0.79
97 The MnSOD Val9Ala polymorphism, dietary antioxidant intake, risk and survival in ovarian cancer (Australia). Gynecol Oncol 2007 0.79
98 The inhibitory effect of small interference RNA protein kinase C-alpha on the experimental proliferative vitreoretinopathy induced by dispase in mice. Int J Nanomedicine 2013 0.79
99 CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study. Breast Cancer Res 2005 0.79
100 Interaction of natural polyphenols with α-amylase in vitro: molecular property-affinity relationship aspect. Mol Biosyst 2011 0.78
101 Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer development. Hugo J 2010 0.78
102 The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 2012 0.78
103 Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 2009 0.78
104 Determination of phthalate esters in water samples by ionic liquid cold-induced aggregation dispersive liquid-liquid microextraction coupled with high-performance liquid chromatography. Anal Chim Acta 2011 0.78
105 Effect of CdTe QDs on the protein-drug interactions. Nanotoxicology 2011 0.77
106 Enhanced Stability and Reusability of Alcohol Dehydrogenase Covalently Immobilized on Magnetic Graphene Oxide Nanocomposites. J Nanosci Nanotechnol 2015 0.77
107 Advances on the interaction between tea catechins and plasma proteins: structure-affinity relationship, influence on antioxidant activity, and molecular docking aspects. Curr Drug Metab 2013 0.77
108 Inhibition of flavonoids on acetylcholine esterase: binding and structure-activity relationship. Food Funct 2014 0.77
109 Molecular property-affinity relationship of the interaction between dietary polyphenols and bovine milk proteins. Food Funct 2011 0.77
110 Multivalent capture and detection of cancer cells with DNA nanostructured biosensors and multibranched hybridization chain reaction amplification. Anal Chem 2014 0.77
111 Structures required of polyphenols for inhibiting advanced glycation end products formation. Curr Drug Metab 2013 0.77
112 Influence of glucose on the human serum albumin-flavone interaction and their antioxidant activity. Mol Biosyst 2012 0.77
113 BMP9-induced osteogenic differentiation is partially inhibited by miR-30a in the mesenchymal stem cell line C3H10T1/2. J Mol Histol 2015 0.76
114 Up-regulation of FoxN4 expression in adult spinal cord after injury. J Mol Neurosci 2013 0.76
115 Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers. Breast Cancer Res Treat 2012 0.75
116 Screening and identification of BSA bound ligands from Puerariae lobata flower by BSA functionalized Fe₃O₄ magnetic nanoparticles coupled with HPLC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2012 0.75
117 Investigation of the mechanism of enhanced effect of EGCG on huperzine A's inhibition of acetylcholinesterase activity in rats by a multispectroscopic method. J Agric Food Chem 2008 0.75
118 Rituximab in the treatment of severe lupus myelopathy. Clin Rheumatol 2011 0.75
119 Antitumor effects of naturally occurring oligomeric resveratrol derivatives. FASEB J 2013 0.75
120 Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet 2015 0.75
121 Discovery of temperature-dependent, autoinductive reversal of enantioselectivity: palladium-mediated [3+3]-annulation of 4-hydroxycoumarins. Chem Commun (Camb) 2017 0.75
122 Role of the MAPKs/TGF-β1/TRAF6 signaling pathway in atrial fibrosis of patients with chronic atrial fibrillation and rheumatic mitral valve disease. Cardiology 2014 0.75
123 Analysis of tyrosinase binders from Glycyrrhiza uralensis root: evaluation and comparison of tyrosinase immobilized magnetic fishing-HPLC and reverse ultrafiltration-HPLC. J Chromatogr B Analyt Technol Biomed Life Sci 2013 0.75
124 [Isolation, purification and identification of geniposidic acid in Eucommia ulmoides oliv. by silica column chromatography, reversed-phase high performance liquid chromatography, liquid chromatography-electrospray ionization mass spectrometry and nuclear magnetic resonance]. Se Pu 2005 0.75
125 Influence of dietary flavonoids on the glycation of plasma proteins. Mol Biosyst 2012 0.75
126 [Determination of residual acrylate monomers in adhesives by headspace gas chromatography-mass spectrometry]. Se Pu 2011 0.75
127 Preparative isolation and analysis of alcohol dehydrogenase inhibitors from Glycyrrhiza uralensis root using ultrafiltration combined with high-performance liquid chromatography and high-speed countercurrent chromatography. J Sep Sci 2014 0.75
128 Enantioseparation of racemic mixtures based on solvent sublation. Chirality 2012 0.75
129 On-line two-dimensional LC: a rapid and efficient method for the determination of enantiomeric excess in reaction mixtures. J Sep Sci 2013 0.75
130 Standard fluoroscopic views in cadavers for determining the entry point and depth of a guide needle for use in transpedicular procedures of the thoracolumbar spine. J Clin Neurosci 2010 0.75
131 Glycation of plasma proteins in type II diabetes lowers the non-covalent interaction affinities for dietary polyphenols. Integr Biol (Camb) 2012 0.75
132 A gas-diffusion microfluidic paper-based analytical device (μPAD) coupled with portable surface-enhanced Raman scattering (SERS): facile determination of sulphite in wines. Analyst 2016 0.75
133 Separation and purification of four compounds from Desmodium styracifolium using off-line two-dimensional high-speed counter-current chromatography. J Sep Sci 2013 0.75
134 Eplerenone Prevents Atrial Fibrosis via the TGF-β Signaling Pathway. Cardiology 2017 0.75
135 [Progress in establishment and application of feline calicivirus reverse genetics operating system]. Bing Du Xue Bao 2015 0.75
136 Bovine serum albumin significantly improves the DPPH free radical scavenging potential of dietary polyphenols and gallic acids. Anticancer Agents Med Chem 2012 0.75
137 Structures required of flavonoids for inhibiting digestive enzymes. Anticancer Agents Med Chem 2012 0.75